MedPath

Measurement of Recirculation During Venovenous Extracorporeal Membrane Oxygenation (VV ECMO)

Completed
Conditions
Recirculation
Venovenous Extracorporeal Membrane Oxygenation
Registration Number
NCT00920062
Lead Sponsor
Transonic Systems Inc.
Brief Summary

This study is to test the usefulness of ultrasound dilution recirculation measurements in patients receiving venovenous extracorporeal membrane oxygenation as therapy. The ultrasound dilution measurements determine the efficiency of support provided by venovenous extracorporeal membrane oxygenation. At the present time there are no other devices available to make recirculation measurements.

Detailed Description

At the present time there are no devices available to measure recirculation in patients on venovenous extracorporeal membrane oxygenation. The study uses an external monitor, laptop computer, clamp on flowsensors and ultrasound dilution technology to measure blood flow. Measurements are made by injecting 0.5 - 1 ml/kg of sterile isotonic saline into the patient's extracorporeal circuit. The subject will be monitored throughout the measurements. The measurements will be coordinated with the regular care of the patient and their extracorporeal circuit.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Patients between 0 and 21 years of age
  • Patients receiving venovenous extracorporeal membrane oxygenation as treatment.
Exclusion Criteria
  • Patients over 21 years of age
  • Patients not receiving venovenous extracorporeal membrane oxygenation.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recirculation measurements made in patients receiving venovenous extracorporeal membrane oxygenation.Duration of venovenous extracorporeal membrane oxygenation
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Crouse Hospital

🇺🇸

Syracuse, New York, United States

© Copyright 2025. All Rights Reserved by MedPath